Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Wright

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
American Journal of Clinical Pathology|September 7, 2018
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity TrialThomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Lancet (London, England)|January 26, 2002
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort studyLois J Conley, Tedd V Ellerbrock, Timothy J Bush, et al.
American Journal of Obstetrics and Gynecology|December 11, 2012
APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology resultsMark H Stoler, Thomas C Wright, Jack Cuzick, et al.
International Journal of Cancer|September 7, 2019
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENAMark H Stoler, Ed Baker, Sean Boyle, et al.
The Lancet. Oncology|August 26, 2011
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA studyPhilip E Castle, Mark H Stoler, Thomas C Wright, et al.
American Journal of Public Health|December 30, 2006
Alliance for cervical cancer prevention: setting the record straightJacqueline Sherris, Thomas C Wright, Lynette Denny, et al.
American Journal of Obstetrics and Gynecology|July 16, 2003
2001 consensus guidelines for the management of women with cervical intraepithelial neoplasiaThomas C Wright, J Thomas Cox, L Stewart Massad, et al.
The American Journal of Surgical Pathology|April 27, 2018
Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN StudyMark H Stoler, Thomas C Wright, Alex Ferenczy, et al.
Gynecologic Oncology|March 12, 2019
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trialThomas C Wright, Valentin Parvu, Mark H Stoler, et al.
Gynecologic Oncology|June 14, 2008
Age considerations when vaccinating against HPVThomas C Wright, Warner K Huh, Bradley J Monk, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
American Journal of Clinical Pathology|September 7, 2018
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity TrialThomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Lancet (London, England)|January 26, 2002
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort studyLois J Conley, Tedd V Ellerbrock, Timothy J Bush, et al.
American Journal of Obstetrics and Gynecology|December 11, 2012
APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology resultsMark H Stoler, Thomas C Wright, Jack Cuzick, et al.
International Journal of Cancer|September 7, 2019
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENAMark H Stoler, Ed Baker, Sean Boyle, et al.
The Lancet. Oncology|August 26, 2011
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA studyPhilip E Castle, Mark H Stoler, Thomas C Wright, et al.
American Journal of Public Health|December 30, 2006
Alliance for cervical cancer prevention: setting the record straightJacqueline Sherris, Thomas C Wright, Lynette Denny, et al.
American Journal of Obstetrics and Gynecology|July 16, 2003
2001 consensus guidelines for the management of women with cervical intraepithelial neoplasiaThomas C Wright, J Thomas Cox, L Stewart Massad, et al.
The American Journal of Surgical Pathology|April 27, 2018
Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN StudyMark H Stoler, Thomas C Wright, Alex Ferenczy, et al.
Gynecologic Oncology|March 12, 2019
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trialThomas C Wright, Valentin Parvu, Mark H Stoler, et al.
Gynecologic Oncology|June 14, 2008
Age considerations when vaccinating against HPVThomas C Wright, Warner K Huh, Bradley J Monk, et al.
Pageof 14